Arman Esfandiari

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

Chiao‐En Wu, Arman Esfandiari, Yi-Hsuan Ho et al. · British Journal of Cancer · 2017 · 63 citations · Full text

Medicine, Cancer Biology, Oncology +16

MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models

Francesca Vena, Ruochen Jia, Arman Esfandiari et al. · Oncotarget · 2018 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner

Arman Esfandiari, Thomas A. Hawthorne, Sirintra Nakjang et al. · Molecular Cancer Therapeutics · 2016 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +14

Performance Prediction of Two-Stepped Planing Hulls Using Morphing Mesh Approach

Abbas Dashtimanesh, Arman Esfandiari, Simone Mancini · Journal of Ship Production and Design · 2017 · 44 citations

Engineering, Marine Engineering, Fluid Dynamics +15

ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma

Chiao‐En Wu, Tsin Shue Koay, Arman Esfandiari et al. · Cancers · 2018 · 40 citations · Full text

Medicine, Molecular Biology, Oncology +16